Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DR26FKKD0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,259
Award facts
- Contract value 100% obligated
- $21,259.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,259.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 52 mg Mirena systems (a contraceptive intrauterine device). The award was issued on November 20, 2025, with an ultimate completion date of December 12, 2025. No set-aside designation was used for this competitive procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
The PPV-G GEN V contract, valued at $499,999,999 and awarded to DMS Pharmaceutical Group on November 13, 2025, operates through a 30-month base period with three 30-month option periods extending through December 31, 2036. Under this framework, the Defense Logistics Agency issues delivery orders for branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals to support recurring medical supply needs across military healthcare operations globally. DMS Pharmaceutical Group's demonstrated capability to supply diverse pharmaceutical products—ranging from oncology treatments and immunosuppressants to routine medications and specialty devices—positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FKKD0?
SPE2DR26FKKD0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FKKD0 worth?
The government has obligated $21,259 on SPE2DR26FKKD0.
Is contract SPE2DR26FKKD0 an order under another contract?
Yes. SPE2DR26FKKD0 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKD0 competed?
The extent of competition for SPE2DR26FKKD0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award